Certified by Founder Lodge
Civilization Ventures
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $24,000,000
41 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Civilization Ventures (inquiries to info@civilizationventures.com) invests in visionary founders that are leading the future of health tech and biology-driven innovation. We aim to be the fir
| Company | Date | Round | Raised |
|---|---|---|---|
 Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
 Insamo |
February, 22 ,2024 | Seed | $12,000,000 |
 Tahoe Therapeutics |
August, 12 ,2025 | Unknown | $30,000,000.00 |
 Foresight Diagnostics Inc. |
April, 28 ,2023 | Series B | $58,750,000 |
 Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
 OverT Bio |
May, 07 ,2024 | Seed | $16,000,000 |
 Range Biotechnologies |
June, 13 ,2023 | Seed | $5,200,000 |
 Evonetix Ltd |
February, 10 ,2023 | Series B | $24,000,000 |
 Oxford Cancer Analytics |
January, 10 ,2025 | Series A | $11,000,000 |
 Omada Health |
February, 23 ,2022 | Series E | $192,000,000 |
 BillionToOne |
June, 25 ,2024 | Series D | $130,000,000 |
 Aperiam Bio |
November, 30 ,2023 | Seed | $9,000,000 |
 Sensible Biotechnologies |
April, 07 ,2023 | Pre-Seed | $4,200,000 |
| Tahoe Therapeutics |
August, 12 ,2025 | Unknown | $30,000,000.00 |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Insamo |
February, 22 ,2024 | Seed | $12,000,000 |
| Foresight Diagnostics Inc. |
April, 28 ,2023 | Series B | $58,750,000 |
 Iantrek |
August, 21 ,2025 | Series C | $42,000,000 |
| Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
| OverT Bio |
May, 07 ,2024 | Seed | $16,000,000 |
| Range Biotechnologies |
June, 13 ,2023 | Seed | $5,200,000 |
| BillionToOne |
June, 25 ,2024 | Series D | $130,000,000 |
| Oxford Cancer Analytics |
January, 10 ,2025 | Series A | $11,000,000 |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Aperiam Bio |
November, 30 ,2023 | Seed | $9,000,000 |
| Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
| Tahoe Therapeutics |
August, 12 ,2025 | Unknown | $30,000,000.00 |
| Oxford Cancer Analytics |
January, 10 ,2025 | Series A | $11,000,000 |
| Insamo |
February, 22 ,2024 | Seed | $12,000,000 |
| Tahoe Therapeutics |
August, 12 ,2025 | Unknown | $30,000,000.00 |
| Iantrek |
August, 21 ,2025 | Series C | $42,000,000 |
| Iantrek |
August, 21 ,2025 | Series C | $42,000,000 |
| OverT Bio |
May, 07 ,2024 | Seed | $16,000,000 |
 Trial Library |
December, 03 ,2025 | Series A | $10,000,000 |
| BillionToOne |
June, 25 ,2024 | Series D | $130,000,000 |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
| Oxford Cancer Analytics |
January, 10 ,2025 | Series A | $11,000,000 |
| Tahoe Therapeutics |
August, 12 ,2025 | Unknown | $30,000,000.00 |
| Iantrek |
August, 21 ,2025 | Series C | $42,000,000 |
| Trial Library |
December, 03 ,2025 | Series A | $10,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
